CWM
AMRX icon

CIBC World Markets’s Amneal Pharmaceuticals AMRX Stock Holding History

CIBC World Markets’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$150K Sell
18,542
-16,767
-47% -$126K ﹤0.01% 1338
2025
Q1 		$296K Buy
35,309
+20,417
+137% +$170K ﹤0.01% 1256
2024
Q4 		$118K Buy
+14,892
New +$125K ﹤0.01% 1197

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Markets's AMRX Position: Q2 2025 in Review

CIBC World Markets reduced its Amneal Pharmaceuticals (AMRX) stake by 47% in Q2 2025, selling an estimated $126K and leaving 18,542 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

CIBC World Markets first reported a position in AMRX in Q4 2024 and has held it in 3 quarters since. The position peaked at $296K in Q1 2025. 241 funds tracked by Wall St. Rank hold AMRX as of Q2 2025.

  • CIBC World Markets held 18,542 shares of Amneal Pharmaceuticals worth $150K as of Q2 2025.
  • CIBC World Markets sold 16,767 Amneal Pharmaceuticals shares in Q2 2025, an estimated $126K.
  • Amneal Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1338 holding.
  • CIBC World Markets first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Amneal Pharmaceuticals position peaked at $296K in Q1 2025.
  • 241 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.